Monday, October 19, 2026

USD/CHF Is 2% Down In The Last 21 Sessions

ViaNews Editorial Team

November 29, 2023

USD/CHF Is 2% Down In The Last 21 Sessions

(VIANEWS) - USD/CHF (USDCHF) has been up by 2.84% for the last 21 sessions. At 13:12 EST on Wednesday, 29 November, USD/CHF (USDCHF) is $0.88.

USD/CHF's yearly highs and lows, it's 2.479% up from its 52-week low and 8.172% down from its 52-week high.

Forex Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions, USD/CHF's Forex is considered to be overbought (>=80).

Previous days news about USD/CHF (USDCHF)

  • Usd/chf struggling to remain on-balance for Monday after a test of 0.8800. According to FXStreet on Monday, 27 November, "The USD/CHF has been sticking close to median prices at the 50-hourSimple Moving Average (SMA), though overall momentum in the pair has remained down ever since the pair lost grip of the 0.9100 handle back in early October.", "On the daily charts, the USD/CHF is seeing a further extension of the recent bearish momentum, dropping away from the 200-day SMA just south of the 0.900 major handle, and the 50-day SMA is set for a downside acceleration and the 50- and 200-day SMAs are looking at a bearish crossover in short order."
  • Usd/chf attempts to rebound from three-month lows, trades above 0.8800. According to FXStreet on Tuesday, 28 November, "The USD/CHF pair struggles to halt the losses due to the weaker US Dollar (USD) following the likelihood of the US Federal Reserve (Fed) to conclude its monetary rate hike cycle. "

More news about USD/CHF (USDCHF).

ViaNews Editorial Team

Via News Editorial Team delivers comprehensive financial news coverage and market analysis from journalists around the world. Our team specializes in data journalism and in-depth reporting on stock markets, business developments, and economic trends.

What we know · the intelligence behind this page
Live from the substrate
What we're seeing
Autumn 2026 Governance Reshuffle: CEO Successions, Activist Settlements and Corporate Separations
Across sectors, boards are replacing or rotating leadership (Bausch + Lomb's abrupt CEO exit, Keyser's move to advisor, Deputy CEO promotions, Brown-Forman and BellRing successions). At the same time, activist pressure is being settled through cooperation agreements and board seats (Stride/Fivespan, Al Shams) and through structural separations (National Fuel's IUG spin-out, NGEx). The common thread is boards using governance levers such as new committees, advisory seats and planned succession to reset capital allocation and strategy. Public messaging stresses continuity and partnership, but the number of interim appointments and activist-driven changes points to underlying pressure.
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
ING Group
Both facts record the same metric (shares_outstanding) for ING Group at the identical observation date (2025-12-31). FACT A states 2,902,437,688 shares; FACT B states 2,902 million shares (2,902,000,000). The difference is 437,688 shares (~0.015%). This is a genuine value conflict, though the discrepancy appears to result from FACT B rounding to the nearest million while FACT A provides the precise count.
We flag conflicts openly ›
Recently verified
✓ Checked against the original source
4,986
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,986 facts checked against source5,396 source documents archived
Query this data → isubstrate.com